Raymond C. Kurzweil's most recent trade in United Therapeutics Corp was a trade of 15,000 Common Stock done at an average price of $175.4 . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 28 Feb 2025 | 15,000 | 27,080 (0%) | 0% | 175.4 | 2,631,450 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 15,000 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 315.26 per share. | 28 Feb 2025 | 4,821 | 20,000 (0%) | 0% | 315.3 | 1,519,850 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 314.25 per share. | 28 Feb 2025 | 2,259 | 24,821 (0%) | 0% | 314.3 | 709,900 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 316.07 per share. | 28 Feb 2025 | 2,256 | 17,744 (0%) | 0% | 316.1 | 713,060 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 320.43 per share. | 28 Feb 2025 | 1,519 | 14,025 (0%) | 0% | 320.4 | 486,738 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 318.28 per share. | 28 Feb 2025 | 1,303 | 15,544 (0%) | 0% | 318.3 | 414,713 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 321.53 per share. | 28 Feb 2025 | 1,095 | 12,930 (0%) | 0% | 321.5 | 352,070 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 317.33 per share. | 28 Feb 2025 | 897 | 16,847 (0%) | 0% | 317.3 | 284,647 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 322.43 per share. | 28 Feb 2025 | 750 | 12,180 (0%) | 0% | 322.4 | 241,821 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale of securities on an exchange or to another person at price $ 323.53 per share. | 28 Feb 2025 | 100 | 12,080 (0%) | 0% | 323.5 | 32,353 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 1,440 | 1,440 | - | - | Stock Options | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 590 | 590 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2024 | 900 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2024 | 900 | 12,080 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | C. Kurzweil Raymond | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 23 Feb 2024 | 15,000 | 26,180 (0%) | 0% | 88.0 | 1,320,450 | Common Stock |
| United Therapeutics Corp | C. Kurzweil Raymond | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 15,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | C. Raymond Kurzweil | Director | Sale or transfer of securities back to the company at price $ 227.03 per share. | 23 Feb 2024 | 15,000 | 11,180 (0%) | 0% | 227.0 | 3,405,450 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 2,280 | 2,280 | - | - | Stock Options | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 900 | 900 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 880 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 880 | 11,180 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 15,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 219.17 per share. | 09 Aug 2022 | 15,000 | 10,300 (0%) | 0% | 219.2 | 3,287,550 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 09 Aug 2022 | 15,000 | 25,300 (0%) | 0% | 63.9 | 958,500 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2022 | 1,080 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2022 | 1,080 | 10,300 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 3,230 | 3,230 | - | - | Stock Options | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 1,080 | 1,080 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 1,680 | 9,220 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 1,680 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Sale or transfer of securities back to the company at price $ 171.21 per share. | 26 Mar 2021 | 3,750 | 7,540 (0%) | 0% | 171.2 | 642,038 | Common Stock |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2021 | 3,750 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 26 Mar 2021 | 3,750 | 11,290 (0%) | 0% | 54.8 | 205,388 | Common Stock |